Legal Representation
Attorney
Sarah J. Schneider
USPTO Deadlines
Next Deadline
1240 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-12-13)
Due Date
December 13, 2028
Grace Period Ends
June 13, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
41 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 26, 2023 | INNA | R | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | Loading... |
| Oct 24, 2023 | INPR | P | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | Loading... |
| Oct 22, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Apr 24, 2023 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Apr 4, 2023 | NURC | C | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 1, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Mar 31, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Mar 13, 2023 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Feb 27, 2023 | LIME | I | LIMITATION FROM THE IB EXAMINED AND ENTERED | Loading... |
| Feb 24, 2023 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Feb 24, 2023 | COC. | O | CORRECTION UNDER SECTION 7 - PROCESSED | Loading... |
| Feb 24, 2023 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Dec 15, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Dec 15, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 15, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 15, 2022 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
| Dec 15, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 15, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Dec 13, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Dec 13, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Dec 10, 2022 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | Loading... |
| Sep 27, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 27, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 27, 2022 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Sep 7, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 7, 2022 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Sep 7, 2022 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Aug 22, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 22, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 22, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 22, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 25, 2022 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| May 1, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| May 1, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Mar 19, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 18, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 15, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 21, 2022 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Nov 23, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Nov 19, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 18, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Diagnostic preparations and materials *, not including glucose measurement tests, ovulation tests, drug tests, human chorionic gonadotropin (hCG) tests or HemoActives sold in pharmacies to individual customers * for medical purposes; biochemical preparations for the treatment of cancer; biological preparations for the treatment of cancer; chemical preparations for the treatment of cancer; chemical preparations for veterinary purposes, specifically for the treatment of cancer; nucleic acid sequences for medical and veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing; reagents for medical use
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Analytical medical laboratory services; blood analysis services; blood analysis services for scientific research purposes; consultancy in the field of scientific research; contract research services relating to molecular sciences; design and development of medical technology; laboratory services namely DNA testing services to determine paternity; genetic scientific research; laboratory analysis in the field of bacteriology; laboratory research in the field of gene expression; medical laboratory services; laboratory services for analytical testing; laboratory testing in the field of genetics and genetic engineering; provision of information relating to scientific research; research and development in the field of biotechnology; research laboratories in the pharmaceutical and biotechnology fields; scientific laboratory services; scientific research; scientific research and analysis in the field of genetics and genetic engineering; scientific research for medical purposes; scientific research conducted using databases; scientific services, namely scientific laboratory services; scientific testing services in the field of genetics and genetic engineering; medical and pharmacological research services
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Human healthcare services; medical services; genetic counseling; genetic testing of animals for diagnostic or treatment purposes; health care services offered through a network of health care providers on a contract basis; cancer screening services; laboratory analysis services relating to the treatment of persons provided by medical laboratories; medical and healthcare clinics; medical and healthcare services; medical services, namely monitoring of patients; pathology services, namely, analysis services, diagnostic services and monitoring services for studying diseases
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Other
In the statement, " International Class 5 " is corrected per the fnote dated 2/15/2023
Classification
International Classes
005
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"DIAGNOSTICS"